|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.69 HKD | -2.31% |
|
+15.75% | -53.31% |
| Apr. 25 | Jacobio Pharmaceuticals Plans Auditor Change | MT |
| Apr. 09 | Jacobio to Share Clinical Data of Anti-Tumor Drugs at US Convention | MT |
Jacobio Pharmaceuticals Group Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 63.52 million compared to CNY 95.75 million a year ago. Net loss was CNY 359.12 million compared to CNY 371.86 million a year ago.
Basic loss per share from continuing operations was CNY 0.46 compared to CNY 0.49 a year ago. Diluted loss per share from continuing operations was CNY 0.46 compared to CNY 0.49 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -53.31% | 175M | |
| -3.46% | 102B | |
| +1.41% | 96.29B | |
| +2.13% | 22.18B | |
| -15.84% | 21.2B | |
| -9.21% | 18.31B | |
| -39.98% | 17.38B | |
| -14.65% | 16.36B | |
| +4.39% | 13.97B | |
| +31.35% | 12.17B |
JACOBIO PHARMACEUTICALS GROUP CO., LTD. 
